Exploiting the Immunological Environment Supporting HIV-1 BnAb Induction During Infection to Inform Vaccine Design iconExploiting the Immunological Environment Supporting HIV-1 BnAb Induction During Infection to Inform Vaccine Design

Exploiting the Immunological Environment Supporting HIV-1 BnAb Induction During Infection to Inform Vaccine Design

Jun 3, 2021 8:25am ‐ Jun 3, 2021 8:50am
Designing Immunization Regimens to Promote the Germinal Center Response iconDesigning Immunization Regimens to Promote the Germinal Center Response

Designing Immunization Regimens to Promote the Germinal Center Response

Jun 3, 2021 8:50am ‐ Jun 3, 2021 9:15am
Targeting HIV-1 ENV V2-apex bNAb Precursors in Human Ig Knock-in Mouse Models iconTargeting HIV-1 ENV V2-apex bNAb Precursors in Human Ig Knock-in Mouse Models

Targeting HIV-1 ENV V2-apex bNAb Precursors in Human Ig Knock-in Mouse Models

Jun 3, 2021 9:15am ‐ Jun 3, 2021 9:40am
Short Talk: HLA-II Associated Viral Adaptation Impacts the Quantity and Quality of CD4+ T-Cell Responses in HIV-1 Vaccine Recipients iconShort Talk: HLA-II Associated Viral Adaptation Impacts the Quantity and Quality of CD4+ T-Cell Responses in HIV-1 Vaccine Recipients

Short Talk: HLA-II Associated Viral Adaptation Impacts the Quantity and Quality of CD4+ T-Cell Responses in HIV-1 Vaccine Recipients

Jun 3, 2021 9:40am ‐ Jun 3, 2021 9:55am
Short Talk: Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies iconShort Talk: Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies

Short Talk: Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies

Jun 3, 2021 9:55am ‐ Jun 3, 2021 10:10am
Short Talk: Fusion Peptide Priming and Long Trimer Interval Reduces Off-target Antibody Responses Toward the HIV-1 Trimer Base Region iconShort Talk: Fusion Peptide Priming and Long Trimer Interval Reduces Off-target Antibody Responses Toward the HIV-1 Trimer Base Region

Short Talk: Fusion Peptide Priming and Long Trimer Interval Reduces Off-target Antibody Responses Toward the HIV-1 Trimer Base Region

Jun 3, 2021 10:10am ‐ Jun 3, 2021 10:25am
Coffee Break iconCoffee Break

Coffee Break

Jun 3, 2021 10:25am ‐ Jun 3, 2021 10:45am
Latest Developments in CMV-Vectored HIV/SIV Vaccines iconLatest Developments in CMV-Vectored HIV/SIV Vaccines

Latest Developments in CMV-Vectored HIV/SIV Vaccines

Jun 3, 2021 10:45am ‐ Jun 3, 2021 11:10am
CD8 T Cell Inducing Vaccines iconCD8 T Cell Inducing Vaccines

CD8 T Cell Inducing Vaccines

Jun 3, 2021 10:45am ‐ Jun 3, 2021 12:25pm
Understanding HLA-E Mediated Antigen Presentation to Inform Vaccine Design iconUnderstanding HLA-E Mediated Antigen Presentation to Inform Vaccine Design

Understanding HLA-E Mediated Antigen Presentation to Inform Vaccine Design

Jun 3, 2021 11:10am ‐ Jun 3, 2021 11:35am